TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma (Q83919556)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

invasive ductal carcinoma

29 January 2020

main subject

1 reference

pancreatic ductal adenocarcinoma

inferred from title

1 reference

pancreatic ductal carcinoma

inferred from title

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Trauzold A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Siegmund D

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Schniewind B

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sipos B

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Egberts J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Zorenkov D

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Emme D

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Röder C

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Kalthoff H

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

5 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

7434-7439

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751802%20AND%20SRC:MED&resulttype=core&format=json

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Type I and type II reactions in TRAIL-induced apoptosis -- results from dose-response studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Death receptor-induced signaling pathways are differentially regulated by gamma interferon upstream of caspase 8 processing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Tumor therapeutics by design: targeting and activation of death receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209719

7 January 2021